GeneSight Mental Health Monitor: Special Election Series Phase III Update

October 24, 2024News & Press

The latest installment of the GeneSight^® Mental Health Monitor: Special Election Series, shows that as Election Day draws closer, Americans’ anxiety and/or depression around the 2024 Presidential Election remains significantly elevated.

The nationwide survey from Myriad Genetics, Inc, conducted in September 2024, is the final in a three-part series tracking how the election season is affecting American’s mental health, particularly amidst the ongoing mental health crisis in the United States.

Anxiety and/or depression around the election was already elevated during Phase I of the survey in May 2024, with 40% of Americans reporting feelings of depression and/or anxiety about the upcoming election. These levels have stayed elevated, with 45% feeling anxious or depressed in July, and 41% reporting similar feelings in September.

Additionally, of those who are already suffering from anxiety and/or depression, 50% reported feeling anxious and/or depressed about the election in May. Of the same population, 66% reported feeling anxious/depressed about the election in July, and 59% in September.

Phase III results of the survey also revealed that month-over-month depression and/or anxiety symptoms continue to worsen in the lead up to the election. As of September, those experiencing symptoms of anxiety and/or depression reported increased anxiety due to the news and social media around the election. In May, 49% reported increased anxiety, rising to 60% in July and just slightly decreased to 56% in September.

“It’s unfortunate that Americans’ mental health continues to be negatively affected by election season,” said Thomas J. Valente, M.D., a psychiatrist in Leesburg, Florida. “This multi-phase survey has showed that as campaigning ramped up, Americans’ mental health deteriorated. Given our country’s ongoing mental health crisis, this is a cause for concern.”

For individuals struggling with their mental health, the GeneSight test could be a useful tool as it provides clinicians with information about how their genes may affect how they break down or respond to certain medications commonly prescribed to treat depression, anxiety, and other mental health conditions.

“We hope that Americans will consider taking steps to improve their mental health given this important election is right around the corner,” said Valente. “The GeneSight test is one of the tools I’ve used to help my patients get back on the road to mental wellness.”

About the GeneSight Mental Health Monitor

The GeneSight Mental Health Monitor is a nationwide survey conducted online by ACUPOLL Precision Research, Inc. Phase I was conducted between May 8-15, 2024, Phase II was conducted between July 23-30, 2024, and Phase III was conducted between September 16-23, 2024 among a representative sample (n=1000) of U.S. adults age 18+. The margin of error in survey results for the total base population at a 95% confidence interval is +/- 3%. A nationally representative sample of adults aged 18 years or older was recruited and balanced to match U.S. Census quotas across five primary metrics (i.e., age, gender, income, region, ethnicity).

In addition to the nationally representative sample, a statistically reliable sample was desired of respondents who were self-reported as being diagnosed by a medical professional with depression or anxiety. The study also used mental health screening instruments, the Patient Health Questionnaire-2 (PHQ-2) for depression, and the General Anxiety Disorder (GAD-2) for anxiety, to better understand this population.

ACUPOLL has more than 30 years of experience conducting statistically valid research through careful recruiting and quality control measures.

Dr. Whitnee Brown, DNP, CRNP, PMHNP, FNP, reviewing the GeneSight test results with her patient.

Healthcare Provider

Overcoming Side Effect Concerns: Leveraging Pharmacogenomic Insights to Inform Depression and Anxiety Medication Selection

Whitnee Brown, a lifelong resident now practicing in Birmingham, Alabama has nearly an entire alphabet following her name, abbreviations for degrees and certifi...

Patient

Concerns about Mental Health Medication Side Effects Remain a Barrier to Getting Help for Those Diagnosed with Depression and Anxiety

Lisa Roberts has raised a family, reached an impressively high level in her career, and was an anchor for her mother and other family members. When, within ...

Young man holds one pill and glass of water in hands taking antidepressant medication.

Patient

Common Antidepressant Side Effects

Taking an antidepressant can be an effective way to help treat a mental health condition like depression or anxiety. However, these medications can also cre...

Gene study in a DNA chain showing a mutation like those in the MTHFR gene.

Patient

MTHFR Mutations: Clinical Implications and Management Strategies

MTHFR mutations—changes in the methylenetetrahydrofolate reductase (MTHFR) gene—have gained increased attention in the medical community due to their potent...

Woman Using Mobile mental health app that asks her to answer the question “What is your mood today?"

Patient

Can an App Help Me Manage My Anxiety?

Health and wellness smartphone apps have become so common that if you can name a health goal, desire or condition, you can probably find an app for it. N...

Patient

Black Trailblazers of Psychiatry and Mental Health: A Legacy of Healing and Advocacy

As we celebrate Black History Month, we want to recognize a few individuals who have made extraordinary contributions to the field of psychiatry and mental heal...

Patient

Mindful Moments: Tips for Anxiety

If a well-meaning friend or family member has ever told you to “just breathe” when you’re feeling worked up or stressed out, you’d be forgiven if you felt l...

Patient

Hints To Help You Have A Better New Year

The holidays have ended, and a new year has begun—a time when many embrace a fresh start by setting New Year’s resolutions. This year, why not consider s...

image of stepping stones in a stream indicating the importance of taking one step forward for mental health

Patient

Movement as Medicine: Solutions for Anxiety

Moving forward. It sounds like a nice idea, especially when you’re feeling stuck deep in the throes of an anxiety spiral. But it turns out that physically m...

Two packages of 5 dosing pens each of a fictitious Semiglutin drug used for weight loss (antidiabetic medication or anti-obesity medication) on a blue transparent background. Fictitious package design

Patient

Weight-Loss Drugs and Mental Health: What You Need to Know

New medications for weight loss seem to be flying off pharmacy shelves these days. But could they be linked to mental health conditions? Researchers are ...

Learn more

Learn more about GeneSight
How to talk to your provider
View our clinical studies

Take the next step with the GeneSight test

Take a step closer to getting the GeneSight test or registering to provide the test to your patients. We will follow up with additional information either via email or phone.

The GeneSight test must be ordered by a registered clinician. If you are a patient, caregiver or office staff who would like a clinician to be registered to administer the GeneSight test, please include their name and contact information.

If you are a current registered provider or tested patient, please contact us.

#submit_button {display:none; } To submit this form it is necessary to enable Javascript and refresh the page.

Take the Next Step - PD

Step 1
Step 2
Step 3

Please provide us with your name

First Name

Last Name

I Am A...

Step 1
Step 2
Step 3

Please provide contact and clinic information

Please provide contact information

Date of Birth (MM/DD/YYYY)

We are asking for Date of Birth for data verification purposes.

Job Title

Zip Code

Phone

Would you like to provide the patient's information?

Relationship to Patient

Patient First Name

Patient Last Name

Patient Zip Code

Patient Date of Birth (MM/DD/YYYY)

We are asking for Date of Birth for data verification purposes.

Are you interested in us contacting the patients' clinician about GeneSight?

If you do not have a clinician, we have a directory of healthcare providers who are registered to order the GeneSight test. When you complete this form, we will link you to this directory, so you will have the option to view registered GeneSight providers in your area.

Patient's Doctor's First Name

Patient's Doctor's Last Name

Patient's Clinic Name

Patient's Clinic Zip

Patient's Clinic Phone

Referring a Clinician to Order?

Your clinician who is currently managing your medication and making treatment decisions can order your GeneSight test.

Please provide your clinician's information

The GeneSight test must be ordered by your clinician

NPI

Clinic Name

Clinic Phone

Clinic Zip

Would you like to provide information for the prescribing clinician?

Prescribing Clinician NPI

Prescribing Clinician First Name

Prescribing Clinician Last Name

Step 1
Step 2
Step 3

How can we help?

When completed, we'll follow up with more information

Please let us know how we can best help you

When completed, we'll follow up with more information

How Can We Help You?

If you are a patient or a caregiver and would like to request a copy of your results, please complete the Patient Report Request form here

How Can We Help You?

Additional Details

Do you live in the United States?

We would love to communicate with you about our programs, products, and services. We will always treat your personal details with the utmost care and will never sell them to other companies for marketing purposes. Your consent may be withdrawn at any time using the unsubscribe link provided in all of Myriad’s email communications.

Yes please, I would like to hear about programs, products, and services. No thanks, I do not want to hear about programs, products, and services.

Prove you're human: 2+2=?

How can we help?

Contact Information

By submitting your information in this form, you agree that your personal information may be stored and processed in any country where we have facilities or service providers, and by using our “Take the Next Step” page you agree to the possible transfer of information to countries outside of your country of residence, including to the United States, which may provide for different data protection rules than in your country. The information you submit will be utilized for the sole purpose it was submitted for and governed by our Privacy Notice.